These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2328507)
21. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
22. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis. Merello M; Nouzeilles MI; Arce GP; Leiguarda R Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878 [TBL] [Abstract][Full Text] [Related]
23. [Early morning dystonia: a complication of levodopa therapy in Parkinson disease. Presentation of 4 cases]. Molina Arjona JA; Arnal García C; Calandre Hoenigsfeld L; Bermejo Pareja F Med Clin (Barc); 1984 Jun; 83(2):47-9. PubMed ID: 6471944 [No Abstract] [Full Text] [Related]
25. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II. Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271 [TBL] [Abstract][Full Text] [Related]
26. Forms of dystonia in patients with Parkinson's disease. Kidron D; Melamed E Neurology; 1987 Jun; 37(6):1009-11. PubMed ID: 3587617 [TBL] [Abstract][Full Text] [Related]
27. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations. de la Fuente-Fernández R Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251 [TBL] [Abstract][Full Text] [Related]
28. Cysteine elevation in levodopa-treated patients with Parkinson's disease. Müller T; Kuhn W Mov Disord; 2009 Apr; 24(6):929-32. PubMed ID: 19243072 [TBL] [Abstract][Full Text] [Related]
29. [Reconsiderations in the treatment of Parkinson's disease with levodopa: some pharmacodynamic evidence]. Zappia M; Nicoletti A; Muñoz-S D; Tapia-Núñez J Rev Neurol; 2009 Jul 1-15; 49(1):33-40. PubMed ID: 19557698 [TBL] [Abstract][Full Text] [Related]
30. [Systematic evaluation on influence of dopaminergic therapy: on motor complications in Parkinson's disease]. Zhou MZ; Liu ZG; Chen W; Lu LX; Wu JY; Qi C Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):438-44. PubMed ID: 19567089 [TBL] [Abstract][Full Text] [Related]
31. Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa. Durso R; Evans JE; Josephs E; Szabo GK; Evans BA; Handler JS; Jennings D; Browne TR Ann Neurol; 1997 Sep; 42(3):300-4. PubMed ID: 9307250 [TBL] [Abstract][Full Text] [Related]
32. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study. Kulisevsky J; Pascual-Sedano B; Barbanoj M; Gironell A; Pagonabarraga J; García-Sánchez C Mov Disord; 2007 Jan; 22(1):62-7. PubMed ID: 17115388 [TBL] [Abstract][Full Text] [Related]
33. The spectrum of levodopa-induced dyskinesias. Fahn S Ann Neurol; 2000 Apr; 47(4 Suppl 1):S2-9; discussion S9-11. PubMed ID: 10762127 [TBL] [Abstract][Full Text] [Related]
34. A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease. Ho B; Prakash R; Morgan JC; Sethi KD Nat Clin Pract Neurol; 2007 Sep; 3(9):526-30. PubMed ID: 17805247 [TBL] [Abstract][Full Text] [Related]